November 26, 2019 10:51 AM ESTUpdated 12:06 PM

Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'

In 2018, Shionogi rolled out Xofluza in Japan as a one-dose kill for influenza, with Roche following suit in the US. Soon, though …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Roche's Xofluza may give rise to re­sis­tant strains, rais­ing fears of a 'worst case sce­nar­i­o'